Natural crude drugs to permit clinical study after commercial release

To boost a new natural crude drug development, the KFDA is now preparing a draft reflecting the promotional policy and going to announce it in public around the coming May, which contains special privileges with permission for the clinical studies after its commercial release and exemption of safety data for the registration.

According to the draft, the clinical study may be performed after ...